Insiders

04-08 Incyclix Bio, LLC announced that it has received $46.25 million in funding from a group of investors CI
04-01 Novo's New US Chief on Lilly's Rival Weight-Loss Pill MT
03-26 Geron Corporation Announces the Appointment of Patricia S. Andrews and Constantine Chinoporos to Board of Directors CI
03-26 Faron Pharmaceuticals Ltd Appoints Heikki Jouttijärvi as Chief Technical Officer CI
03-23 Duality Biotherapeutics, Inc. Announces Board and Committee Changes, with Effect from March 23, 2026 CI
03-16 LyondellBasell Announces Management Changes CI
03-12 Global markets live: Tesla, JPMorgan, Amazon, Leonardo… Zonebourse
03-12 Poolbeg Pharma plc Appoints Adrian Kilcoyne to Scientific Advisory Board CI
03-11 Hims & Hers Health, Inc. Appoints Kathryn Beiser as Chief Communications Officer CI
03-09 Global markets live: Live Nation, Eli Lilly, Amazon, Microsoft, ABB… Zonebourse
02-26 Soleno Therapeutics Names New Chief Financial Officer MT
02-24 Novo's stumbles burnish Lilly's widening lead in weight-loss drugs RE
02-23 Tectonic Therapeutic, Inc. Announces Board and Committees Changes CI
02-23 Zura Bio Limited Announces Board Changes, Effective February 21, 2026 CI
02-19 Artiva Biotherapeutics Announces Appointment of Elaine Sorg to Board of Directors CI
02-17 Integra Lifesciences Holdings Corporation Announces Appointments of Executives CI
02-09 Global markets live: Alphabet, Meta, Eli Lilly, Uber, Ocado… Zonebourse
02-09 Wall St struggles for direction as investors await key economic data RE
02-09 PRESS DIGEST-Wall Street Journal - February 9 RE
02-04 Top Midday Stories: Lilly Shares Soar After Strong Q4 Earnings, Guidance; Uber Q4 EPS Misses Target, CFO Stepping Down MT
02-03 Wall St selloff deepens led by software, cloud firms RE
02-03 Bicycle Therapeutics plc Announces Executive Changes CI
01-28 Vera Therapeutics Announces Appointment of Matt Skelton as Chief Commercial Officer, Effective January 28, 2026 CI
01-13 Oncolytics Biotech Inc. Appoints Yujun Wu as Vice President, Head of Biostatistics CI
01-13 Gan & Lee Pharmaceuticals Appoints Dr. John Wang As Senior Vice President And Chief Strategy Officer, Effective January 12, 2026 CI
No results for this search